Global Insulin Pumps Market to 2025
www.theinsightpartners.com
For instance, in July 2018, the Roche received a CE mark for its Accu-Chek Solo micropump system.
The system is a small tube-free insulin delivery device that offers to their users the choice to bolus
directly from the pump. It is fully functional handheld device that comprise detach and re-attach
function of pump without wasting insulin. The Accu-Chek Solo micropump integrates and the
Roche’s digital health solutions contributing in a combination to provide more effective and
personalized diabetes management to their users. Moreover, in the March 2018, the Medtronic
announced to have a FDA approval for their latest smart technology of standalone CGM named the
Guardian Connect system. The Guardian Connect system has the advanced feature including alert
system that helps in aware people about potential high or low glucose level events, up to 60
minutes in advance.
The key players operating in the field of insulin pumps market worldwide include Insulet
Corporation, Medtronic, Tandem Diabetes Care, Inc, Debiotech S.A, CELLNOVO, SOOIL
Developments Co., Ltd, MicroPort, Scientific Corporation, Valeritas Inc., F. Hoffmann-La Roche Ltd.,
Ypsomed AGand and among others.
The report segments the global insulin pumps market as follows:
Global Insulin Pumps Market – By Product
Pumps
Accessories
Global Insulin Pumps Market – By Type
Tethered
Untethered
Global Insulin Pumps Market – By Application
Type I Diabetes
Type II Diabetes
3